v3.26.1
Acquisitions - Additional Information (Details) - USD ($)
 1 Months Ended
Feb. 28, 2019
Jun. 30, 2026
Dec. 31, 2025
Business Acquisition [Line Items]      
Goodwill   $ 140,627,000 $ 140,627,000
Cobalt Biomedicine, Inc | Acquisition Agreement      
Business Acquisition [Line Items]      
Business acquisition, percentage of voting interests acquired 100.00%    
Business acquisition, impairment of intangible assets or goodwill $ 0    
Goodwill 140,600,000    
Maximum contingent consideration upon achievement of certain pre-specified development milestones $ 500,000,000.0    
Maximum term for success payment 20 years    
Estimated fair value of contingent consideration   150,800,000 123,700,000
Cobalt Biomedicine, Inc | Acquisition Agreement | Location, Statement of Financial Position, Balance [Axis]: us-gaap:AccruedLiabilitiesAndOtherLiabilities      
Business Acquisition [Line Items]      
Estimated fair value of contingent consideration   90,800,000 40,200,000
Cobalt Biomedicine, Inc | Acquisition Agreement | Location, Statement of Financial Position, Balance [Axis]: us-gaap:OtherLiabilitiesNoncurrent      
Business Acquisition [Line Items]      
Estimated fair value of success payment liability   23,200,000 17,900,000
Estimated fair value of contingent consideration   $ 60,000,000 $ 83,500,000
Cobalt Biomedicine, Inc | Acquisition Agreement | Minimum      
Business Acquisition [Line Items]      
Threshold market capitalization $ 8,100,000,000    
Cobalt Biomedicine, Inc | Acquisition Agreement | Market Capitalization Equal to or Exceeds $8.1 billion      
Business Acquisition [Line Items]      
Cobalt success payment 500,000,000.0    
Cobalt Biomedicine, Inc | Acquisition Agreement | IPR&D      
Business Acquisition [Line Items]      
Business combination, intangible assets $ 59,200,000